CRMD Q2 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16,443-53.4% YoY

Gross Profit

-$2,741-16.7% margin

Operating Income

-$9M-54251.7% margin

Net Income

-$4M-23003.2% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-77.8%

Cash Flow

Operating Cash Flow

-$754,369

Free Cash Flow

-$758,406

Stock-Based Comp.

$695,590

Balance Sheet

Total Assets

$24M

Total Liabilities

$6M

Stockholders' Equity

$19M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16,443	$35,266	-53.4%
Gross Profit	-$2,741	$14,138	-119.4%
Operating Income	-$9M	-$6M	-61.1%
Net Income	-$4M	-$696,158	-443.3%